By Robert King
Kaiser Permanente reached a tentative deal with the Alliance of Health Care Unions to avert a strike of nearly 32,000 workers set to go into effect Monday.
read more
By Annalee Armstrong
“It took a village to make me.” These words spoken by WeiQing Zhou, who is the cofounder of two biotechs, could apply to almost any of the women on the 2021 Fiercest Women in Life Sciences list.
read more
By Andrea Park
Months after Philips received the FDA’s go-ahead to begin repairing and replacing the ventilators affected by the Class I recall the company initiated in mid-June, the regulator identified a potential safety risk with a replacement component.
read more
By Kevin Dunleavy
Three months after earning an approval to treat chronic heart failure with Jardiance, Eli Lilly and Boehringer Ingelheim have posted data that show the drug’s effectiveness against another type of heart failure.
read more
By Annalee Armstrong
Bristol Myers took the rare step of tapping Johnson & Johnson’s Janssen unit to help develop new anticoagulant medicines back in 2018. Now, the Big Pharmas have the proof-of-concept data they need to prepare the partnership for late stage development.
read more
By Conor Hale
A large-scale clinical trial of Fitbit’s pulse-tracking algorithm showed success in spotting the hidden signs of atrial fibrillation, demonstrating the capability of smartwatches and fitness trackers as a frontline screening device for the potentially dangerous heart condition.
read more
By Fraiser Kansteiner
J&J's type 2 diabetes med Invokana helped improve patients' heart failure symptoms regardless of whether or not they had diabetes, phase 3 data presented at the American Heart Association's virtual Scientific Sessions 2021 showed.
read more
By Emmy Lucas
PhaseBio had already shown its Brilinta reversal agent could work in healthy volunteers, but now the biotech has the phase 3 data to back up the therapy's use in patients who are in an emergency situation.
read more
By Heather Landi
The rise of the highly infectious delta variant in the third quarter had an unexpected impact on telehealth company Amwell's virtual care visits as urgent care services grew but specialty and behavioral health services dropped.
read more
By Annalee Armstrong
Glen de Vries, co-founder of the life sciences software provider Medidata, died in a plane crash last week, less than a month after flying to space with William Shatner aboard a Blue Origin rocket.
read more
By Dave Muoio
The rule aimed to cut down the time between regulatory authorization and Medicare coverage determination for innovative technologies. It was finalized days before Biden took office.
read more
By Andrea Park
With barely a month left in the year, Medtronic is shuffling up its executive team.
read more
By Joseph Keenan
Thermo Fisher Scientific will build a manufacturing facility in North Carolina focused on making vital laboratory products as part of its $192.5 million contract with the U.S. Department of Health and Human Services.
read more
